IMMUNIC, INC. - Common Stock, $0.0001 par value (IMUX) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2019 to Q4 2025

Type / Class
Equity / Common Stock, $0.0001 par value
Symbol
IMUX on Nasdaq
Shares outstanding
136,442,452
Price per share
$0.61
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
48,498,774
Total reported value
$25,882,739
% of total 13F portfolios
0%
Share change
+8,513,031
Value change
+$3,757,929
Number of holders
56
Price from insider filings
$0.61
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of IMMUNIC, INC. - Common Stock, $0.0001 par value (IMUX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Vivo Opportunity Fund Holdings, L.P. 10% $17,767,413 29,126,906 Vivo Opportunity Fund Holdings, L.P. 17 Feb 2026
BIOTECHNOLOGY VALUE FUND L P 10% 0% $8,314,667 +$2,345,708 13,630,601 +39% BVF PARTNERS L P/IL 12 Feb 2026
JANUS HENDERSON GROUP PLC 10% +233% $8,531,675 +$6,622,427 12,016,444 +347% JANUS HENDERSON GROUP PLC 28 Nov 2025
Adage Capital Management, L.P. 10% +422% $8,697,850 +$7,537,012 10,479,337 +649% Adage Capital Management, L.P. 30 Jun 2025
Nantahala Capital Management, LLC 8.2% -18% $7,057,316 -$174,188 10,378,406 -2.4% Nantahala Capital Management, LLC 31 Dec 2025
Aberdeen Group plc 6.8% -19% $4,399,791 8,243,941 0% Aberdeen Group plc 31 Dec 2025
683 Capital Management, LLC 5.9% -40% $5,100,000 -$2,131,423 7,500,000 -29% 683 CAPITAL MANAGEMENT, LLC 31 Dec 2025
Alyeska Investment Group, L.P. 6.2% -35% $5,100,000 -$2,550,000 7,500,000 -33% Alyeska Investment Group, L.P. 31 Dec 2025
Soleus Capital Master Fund, L.P. 5.5% $4,143,120 6,792,000 Soleus Capital Master Fund, L.P. 17 Feb 2026
Avidity Partners Management LP 4.8% -18% $4,143,001 -$807,898 4,699,411 -16% Avidity Partners Management LP 30 Sep 2025
VANGUARD GROUP INC 4.4% $4,473,090 3,923,763 The Vanguard Group 31 Dec 2024
Soleus Private Equity Fund III, L.P. 1.6% $1,392,934 1,580,007 Soleus Capital Management, L.P. 30 Sep 2025
RTW INVESTMENTS, LP 1.1% $1,170,509 1,026,762 RTW Investments, LP 31 Mar 2025
ARMISTICE CAPITAL, LLC 5% -50% $328,030 -$49,773 372,085 -13% Armistice Capital, LLC 30 Sep 2025

As of 31 Dec 2025, 56 institutional investors reported holding 48,498,774 shares of IMMUNIC, INC. - Common Stock, $0.0001 par value (IMUX). This represents 36% of the company’s total 136,442,452 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of IMMUNIC, INC. - Common Stock, $0.0001 par value (IMUX) together control 35% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Aberdeen Group plc 6% 8,243,941 0% 0.01% $4,399,791
BVF INC/IL 5.6% 7,652,972 0% 0.14% $4,084,391
VANGUARD GROUP INC 3.7% 5,020,337 +16% 0% $2,680,860
Avidity Partners Management LP 3.4% 4,699,411 0% 0.72% $2,508,076
Nantahala Capital Management, LLC 3.2% 4,378,406 0.14% $2,336,755
Laurion Capital Management LP 2.8% 3,882,162 +106% 0.14% $2,071,910
MILLENNIUM MANAGEMENT LLC 2.5% 3,419,299 +545% 0% $1,824,880
MORGAN STANLEY 1.5% 2,091,010 -33% 0% $1,115,972
ADAGE CAPITAL PARTNERS GP, L.L.C. 1% 1,398,600 0% 0% $746,433
GEODE CAPITAL MANAGEMENT, LLC 0.86% 1,176,285 +14% 0% $627,944
MARSHALL WACE, LLP 0.75% 1,019,983 +91% 0% $540,592
BlackRock, Inc. 0.53% 717,470 -1.1% 0% $382,913
Ikarian Capital, LLC 0.49% 674,662 -26% 0.05% $360,067
UBS Group AG 0.39% 537,118 +1288% 0% $286,822
GSA CAPITAL PARTNERS LLP 0.39% 527,455 +173% 0.02% $282,000
Squarepoint Ops LLC 0.26% 352,875 +30% 0% $188,329
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.24% 333,829 0% $178,165
STATE STREET CORP 0.24% 331,945 0% 0% $177,159
Connective Capital Management, LLC 0.22% 301,296 0.09% $160,802
JANE STREET GROUP, LLC 0.21% 286,677 +47% 0% $153,000
CITADEL ADVISORS LLC 0.2% 266,806 -50% 0% $142,394
XTX Topco Ltd 0.17% 225,271 0% $120,227
NORTHERN TRUST CORP 0.16% 220,727 +4.4% 0% $117,802
BOOTHBAY FUND MANAGEMENT, LLC 0.1% 130,585 -46% 0% $69,693
Strategies Wealth Advisors, LLC 0.07% 100,000 0% 0.01% $53,370

Institutional Holders of IMMUNIC, INC. - Common Stock, $0.0001 par value (IMUX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 48,498,774 $25,882,739 +$3,757,929 $0.53 56
2025 Q3 42,691,219 $37,637,800 -$6,009,914 $0.88 61
2025 Q2 50,178,419 $35,007,422 +$6,044,822 $0.70 55
2025 Q1 40,453,267 $44,092,350 -$10,908,092 $1.09 63
2024 Q4 51,078,929 $51,080,793 -$5,070,929 $1.00 65
2024 Q3 55,990,706 $92,402,857 +$4,082,986 $1.65 61
2024 Q2 55,825,550 $62,078,863 -$1,856,872 $1.11 57
2024 Q1 57,356,707 $75,746,429 +$55,567,381 $1.32 60
2023 Q4 15,140,220 $22,708,217 -$4,865,374 $1.50 49
2023 Q3 18,373,010 $27,006,486 -$3,552,617 $1.47 53
2023 Q2 20,191,368 $50,673,312 -$8,732,751 $2.51 62
2023 Q1 24,789,103 $36,932,167 +$1,129,629 $1.49 57
2022 Q4 24,354,230 $34,040,740 +$5,454,473 $1.40 59
2022 Q3 17,440,399 $55,106,794 -$3,092,179 $3.16 62
2022 Q2 18,260,665 $63,350,669 -$15,186,048 $3.47 65
2022 Q1 17,606,263 $198,949,802 +$44,387,028 $11.30 78
2021 Q4 13,709,674 $131,117,717 +$7,603,275 $9.57 66
2021 Q3 12,872,467 $113,976,993 +$30,193,655 $8.85 66
2021 Q2 9,434,902 $115,673,222 -$1,395,354 $12.26 56
2021 Q1 9,300,714 $148,252,917 -$6,173,953 $15.94 60
2020 Q4 9,727,941 $148,744,642 +$11,593,540 $15.29 66
2020 Q3 8,546,270 $158,699,665 +$86,090,223 $18.57 64
2020 Q2 4,206,160 $51,019,563 +$24,949,305 $12.12 47
2020 Q1 2,155,699 $13,039,030 +$104,044 $6.01 15
2019 Q4 2,138,466 $20,744,048 +$6,193,891 $9.70 14
2019 Q3 1,499,379 $14,993,920 -$480,203 $10.00 18
2019 Q2 1,536,778 $17,625,202 +$17,623,000 $11.46 20